Clinical Research Directory
Browse clinical research sites, groups, and studies.
Diagnosing Drug Allergy: the T is the Key
Sponsor: University Hospital, Antwerp
Summary
The goal of this clinical trial is to validate a newly developed test in the diagnosis of patients with amoxicillin allergy (i.e. T-cell activation test). The main questions the study aims to assess are the reliability and applicability of this test. Participants will be asked to visit the hospital 1, 3 or 5 times during which blood is collected and when applicable, allergy skin testing is performed.
Official title: Diagnosing Drug Allergy the T is the Key
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2024-05-21
Completion Date
2027-09-30
Last Updated
2025-05-23
Healthy Volunteers
Yes
Conditions
Interventions
T-cell activation test using intracellular markers
A blood sample will be taken which is needed for the T-cell activation test (TAT). The TAT will than be performed by trained laboratory personnel.
Locations (1)
Antwerp University Hospital
Edegem, Antwerp, Belgium